Timeline achievement is central to a successful clinical trial and pivotal to staying within budget. When approaching a project, a sponsor must address how a CRO approaches timelines. Trial Runners shares the sponsor’s commitment to timeline achievement, not just by meeting established timelines but by establishing the most aggressive in the... Read More »
Trial Runners, a full-service ophthalmology CRO, partners with pharmaceutical, biotech and device companies to bring treatments and cures to 1.3 million Americans who are legally blind. While so many patients are afflicted with this debilitating condition, the condition is wrought with misconceptions.
# 1 - Blind people can’t see.
The truth is...Read More »
The final outcome of any clinical trial – the ability to bring new treatments to market – depends on successful patient recruitment and retention despite the unique limitations and challenges of the trial, among other factors. When enrollment initiatives fail or patients discontinue participation before study completion, sponsor costs increase,...Read More »
As a premier ophthalmology CRO, our expertise does not fall short on just the field of ocular indications. Some afflictions of the eye constitute as a rare disease such as Friedrich's Ataxia and Alport Syndrome. Trial Runners has expanded its services to help the rare disease and orphan drug industry to bring comfort and hope to patients suffering...Read More »
Trial Runners is happy to announce that they will be attending the Clinical Trial Innovation Summit in Boston, MA this year. With increased opportunity in the industry for Trial Runners, they have in kind increased their conference visibility, and that means participation in other forefront conferences, summits and congresses in the field of...Read More »
Trial Runners is very excited to announce their participation in the GTC BIO Ocular Diseases Drug Discovery Conference in San Diego! Our conference strategy has led us to the willing attendance of an excellent meeting that takes place in the heart of conference season! The participation level of Trial Runners is of a proud sponsor. We look...Read More »
Trial Runners has big plans for the future as an expanding company in the field of ophthalmology. As an ophthalmology CRO, the company is always looking for new ways to influence the industry with thought leading processes and strategy. The vision of the company includes expanding services and setting goals to continue doing a service to the...Read More »
In the month of January, we honor the awareness and study of a debilitating affliction to the eye. Glaucoma affects a myriad of people across the globe. The growing susceptibility of this debilitating disease is cause for concern in the field of ophthalmology. Glaucoma earned the moniker of "the sneak thief of sight" because the symptoms from the...Read More »
What does your company stand for? This very question can lay the foundation for your company, and there's an excellent tool to help you find your identity.Simon Sinek's signature Golden Circle lays a rudimentary starting point to base company strategy upon. This strategy was implemented with the notion of adapting an emotional appeal to business... Read More »
Dry eye is one of the more common ophthalmic indications that we hope to treat at Trial Runners. There are many treatments for dry eye but let's explore one of the more alternative methods to treat the condition.
The most used methods for treating dry eye would most certainly be topical applications, aka eye drops. These come in many forms, and...Read More »